DMDavid Martínez-Briseño

David Martínez-Briseño

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David Martínez-Briseño has a total of 107 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reference equations for maximal inspiratory and expiratory pressures: From childhood to advanced age

    by Laura Gochicoa-Rangel, Juana Hernández-Ruiz, Taki Moreno-Chavarría, Rocío Nayeli Sánchez-Santillán, Pablo León-Gómez, Silvia Cid-Juárez, Mario Flores-Valadez, Irlanda Alvarado-Amador, Gustavo I. Centeno-Saenz, Mario H. Vargas, et al.

  • Open Access

    The Hypoxia–Retinoid Axis in Idiopathic Pulmonary Fibrosis: Multifaceted Etiology and Therapeutic Potential

    by Daniel Paz-Gomez, Manuel Castillejos-López, Yair Romero, Edgar Flores-Soto, Bianca S. Romero-Martinez, Joel Armando Vázquez-Pérez, Georgina Gonzalez-Avila, Victor Ruiz, Ángeles Carlos-Reyes, Rafael Velázquez-Cruz, et al.

    Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal lung disease with limited therapeutic options. This review focuses on the role of retinoids, particularly all-trans retinoic acid (atRA), and hypoxia in the pathogenesis of IPF. Despite an established understanding of genetic and environmental factors in IPF, the interplay between retinoid signaling and the response to hypoxia remains poorly explored due to its complexity. Preclinical evidence suggests that atRA could help reduce pulmonary fibrosis by modulating TGF-β signaling pathways and epithelial-to-mesenchymal transition (EMT). Additionally, we mention other diseases where a relationship between hypoxia and retinoids has been observed. We review how hypoxia, a key factor in the progression of IPF, may influence the efficacy of retinoid therapy. Combination strategies are explored to overcome hypoxia-induced treatment resistance. Finally, we address the complex role of retinoids in lung regeneration, balancing their potential benefits against the risk of exacerbating fibrotic processes. This review suggests that retinoids have potential as a treatment or adjuvant for IPF and highlights the need for further research to elucidate the precise mechanisms of retinoid action in IPF, particularly in hypoxia.


  • Open Access

    Spirometry at different Latin-American altitudes: A Global Lung Function Initiative project

    by Laura Gochicoa-Rangel, David Martínez-Briseño, Cole Bowerman, Sanja Stanojevic, Luciano Enrique Busi, Santiago C. Arce, Mónica Gutiérrez-Clavería, Carlos E Rodríguez-Martínez, Carlos Aguirre-Franco, Ana Moya-Olivares, et al.

    Approximately 20% of people in Latin American live above 2500 meters above sea level. In this ethnically and socioeconomically diverse population, it is challenging to differentiate the effects of altitude from population differences in lung function.Aim: To quantify the contribution of altitude on the variability in lung function measured by spirometry in Latin America.Methods: Data from healthy individuals living in nine cities across Latin American, (from sea level to >2500 meters above sea level) were collated. Z-scores for FEV1, FVC, and FEV1/FVC were calculated using available reference equations. Mixed-effects linear regression models were used to quantify the variance in spirometry explained by altitude. The percentage of individuals that were below the lower limit of normal (LLN; 5th percentile) were summarized.Results: A total 4480 subjects (3 to 94 years) were included. Average FEV1and FVC z-scores differed between the altitude groups, whereas FEV1/FVC did not. After adjusting for sex, height and age, altitude explained up to ∼18% of the variability in lung function measured by spirometry.Conclusion: For people living at altitude existing approaches to interpret spirometry measures may mis-classify individuals.


  • Evaluation of the Adjustment of Reference Equations for Impulse Oscillometry in Subjects With Down Syndrome Living in Mexico City

    by Rosario Fernández-Plata, Laura Gochicoa-Rangel, Rogelio Pérez-Padilla, Anjarath Higuera-Iglesias, Christian Rodríguez-Hernández, Dalia Cano-Jimenez, Midori Pérez-Kawabe, Manuel Castillejos-López, David Martínez-Briseño

  • Open Access

    Clinical implications of persistently increased blood urea nitrogen/serum creatinine ratio (PI-BUN/Cr) in severe COVID-19 patients

    by Gustavo Casas Aparicio, Rosario Fernández Plata, Anjarath Higuera Iglesias, David Martínez Briseño, Rolando Claure-Del Granado, Manuel Castillejos Lopez, Joel Vázquez Pérez, Noé Alvarado Vásquez, Rafael Velázquez Cruz, Graciela Hernández Silva, et al.

    Patients with COVID-19 may experience a persistent increase in the blood urea nitrogen over creatinine ratio (PI-BUN/Cr). Its elevation could reflect multiple underlying pathophysiological processes beyond prerenal injury but also warrants nuanced interpretation due to its complex interplay with various factors, underscoring the importance of investigating its effects on mortality and acute kidney injury in this population. We analized a retrospective and longitudinal cohort of patients admitted to a single center in Mexico City for patients with severe COVID-19. Between March 5, 2020 and August 25, 2021, we included patients with confirmed positive diagnosis for SARS-CoV-2, age > 18 years, disease severity was defined by clinical data of respiratory distress syndrome and a ratio of partial oxygen pressure to inspired oxygen fraction < 300 mmHg on admission. We excluded patients with End Stage Kidney Disease. Data was obtained from electronic medical records. PI-BUN/Cr was defined as an increase in the BUN/Cr ratio > 30 in more than 60% of measurements in the hospital. The outcomes included: risk factors to mortality and AKI in-hospital. The cohort included 3,007 patients with a median age of 54.6 ± 14.5 years. 35% of patients died; 44.6% developed PI-BUN/Cr ratio and 71.4% AKI. Mortality was associated with older age > 60 years [Hazard ratio (HR)] = 1.45, 95% CI: 1.28–1.65; p < 0.001); male (HR 1.25, 95% CI 1.09–1.44; p = 0.002) and AKI (HR 3.29, 95% CI 2.42–4.46; p < 0.001); PI-BUN/CR & Non-AKI (HR = 2.82, 95% CI: 1.61–4.93; p < 0.001); Non PI-BUN/CR & AKI (HR = 5.47, 95% CI: 3.54–8.44; p < 0.001); and PI-BUN/CR & AKI (HR = 4.26, 95% CI: 2.75–6.62, p < 0.001). Only hiperuricemia was a risk factor for AKI (HR = 1.71, 95% CI: 1.30–2.25, p < 0.001). While PI-BUN/Cr alone may not directly associate with mortality, its capacity to sub-phenotype patients according to their AKI status holds significant promise in offering valuable insights into patient prognosis and outcomes. Understanding the nuanced relationship between PI-BUN/Cr and AKI enhances our comprehension of renal function dynamics. It equips healthcare providers with a refined tool for risk stratification and personalized patient management strategies.


  • Open Access

    Reference equations for DLNO and DLCO in Mexican Hispanics: influence of altitude and race

    by Laura Gochicoa-Rangel, Ada De-Los-Santos-Martínez, Alejandro Reyes-García, David Martínez-Briseño, Mario H Vargas, Irma Lechuga-Trejo, Carlos Guzmán-Valderrábano, Luis Torre-Bouscoulet, Gerald Stanley Zavorsky

    Objectives: This study aimed to evaluate pulmonary diffusing capacity for nitric oxide (DLNO) and pulmonary diffusing capacity for carbon monoxide (DLCO) in Mexican Hispanics born and raised at 2240 m altitude (midlanders) compared with those born and raised at sea level (lowlanders). It also aimed to assess the effectiveness of race-specific reference equations for pulmonary diffusing capacity (white people vs Mexican Hispanics) in minimising root mean square errors (RMSE) compared with race-neutral equations. Methods: DLNO, DLCO, alveolar volume (VA) and gas transfer coefficients (KNO and KCO) were measured in 392 Mexican Hispanics (5 to 78 years) and compared with 1056 white subjects (5 to 95 years). Reference equations were developed using segmented linear regression (DLNO, DLCO and VA) and multiple linear regression (KNO and KCO) and validated with Least Absolute Shrinkage and Selection Operator. RMSE comparisons between race-specific and race-neutral models were conducted using repeated k-fold cross-validation and random forests. Results: Midlanders exhibited higher DLCO (mean difference: +4 mL/min/mm Hg), DLNO (mean difference: +7 mL/min/mm Hg) and VA (mean difference: +0.17 L) compared with lowlanders. The Bayesian information criterion favoured race-specific models and excluding race as a covariate increased RMSE by 61% (DLNO), 18% (DLCO) and 4% (KNO). RMSE values for VA and KCO were comparable between race-specific and race-neutral models. For DLCO and DLNO, race-neutral equations resulted in 3% to 6% false positive rates (FPRs) in Mexican Hispanics and 20% to 49% false negative rates (FNRs) in white subjects compared with race-specific equations. Conclusions: Mexican Hispanics born and raised at 2240 m exhibit higher DLCO and DLNO compared with lowlanders. Including race as a covariate in reference equations lowers the RMSE for DLNO, DLCO and KNO and reduces FPR and FNR compared with race-neutral models. This study highlights the need for altitude-specific and race-specific reference equations to improve pulmonary function assessments across diverse populations.


  • Open Access

    Reference equations using segmented regressions for impulse oscillometry in healthy subjects aged 2.7–90 years

    by Laura Gochicoa-Rangel, David Martínez-Briseño, Selene Guerrero-Zúñiga, Jessica Contreras-Morales, Dulce Arias-Jiménez, Rodrigo Del-Río-Hidalgo, Federico Isaac Hernández-Rocha, Cecilio O. Ceballos-Zúñiga, Mónica Silva-Cerón, Uri De Jesús Mora-Romero, et al.

    Background: Published reference equations for impulse oscillometry (IOS) usually encompass a specific age group but not the entire lifespan. This may lead to discordant predicted values when two or more non-coincident equations can be applied to the same person, or when a person moves from one equation to the next non-convergent equation as he or she gets older. Thus, our aim was to provide a single reference equation for each IOS variable that could be applied from infancy to old age.Methods: This was an ambispective cross-sectional study in healthy nonsmokers, most of whom lived in Mexico City, who underwent IOS according to international standards. A multivariate piecewise linear regression, also known as segmented regression, was used to obtain reference equations for each IOS variable.Results: In a population of 830 subjects (54.0% female) aged 2.7 to 90 years (54.8% children ≤12 years), segmented regression estimated two breakpoints for age in almost all IOS variables, except for R5−R20 in which only one breakpoint was detected. With this approach, multivariate regressions including sex, age, height and body mass index as independent variables were constructed, and coefficients for calculating predicted value, lower and upper limits of normal, percentage of predicted and z-score were obtained.Conclusions: Our study provides IOS reference equations that include the major determinants of lung function,i.e.sex, age, height and body mass index, that can be easily implemented for subjects of almost any age.


  • Open Access

    Risk of Pulmonary Fibrosis and Persistent Symptoms Post-COVID-19 in a Cohort of Outpatient Health Workers

    by Rosario Fernández-Plata, Anjarath-Lorena Higuera-Iglesias, Luz María Torres-Espíndola, Arnoldo Aquino-Gálvez, Rafael Velázquez Cruz, Ángel Camarena, Jaime Chávez Alderete, Javier Romo García, Noé Alvarado-Vásquez, David Martínez Briseño, et al.

    Background: Infection by SARS-CoV-2 has been associated with multiple symptoms; however, still, little is known about persistent symptoms and their probable association with the risk of developing pulmonary fibrosis in patients post-COVID-19. Methods: A longitudinal prospective study on health workers infected by SARS-CoV-2 was conducted. In this work, signs and symptoms were recorded of 149 health workers with a positive PCR test for SARS-CoV-2 at the beginning of the diagnosis, during the active infection, and during post-COVID-19 follow-up. The McNemar chi-square test was used to compare the proportions and percentages of symptoms between the baseline and each follow-up period. Results: The signs and symptoms after follow-up were cardiorespiratory, neurological, and inflammatory. Gastrointestinal symptoms were unusual at the disease onset, but unexpectedly, their frequency was higher in the post-infection stage. The multivariate analysis showed that pneumonia (HR 2.4, IC95%: 1.5–3.8, p < 0.001) and positive PCR tests still after four weeks (HR 5.3, IC95%: 2.3-12.3, p < 0.001) were factors associated with the diagnosis of post-COVID-19 pulmonary fibrosis in this study group. Conclusions: Our results showed that pneumonia and virus infection persistence were risk factors for developing pulmonary fibrosis post-COVID-19, after months of initial infection.


  • Open Access

    Maximal inspiratory and expiratory flow at moderate altitude: a study of a Latin American population

    by Laura Gochicoa-Rangel, Keylin Yaoska Rodríguez-Peralta, Ana Karen Gutiérrez-Bautista, Carlos Guzmán-Valderrábano, Rosario Fernández-Plata, Luis Torre-Bouscoulet, David Martínez-Briseño

    Peak inspiratory and expiratory flows (PIF, PEF) are parameters used to evaluate the mechanics of the respiratory system. These parameters can vary based on whether they are measured using mechanical devices vs. spirometry and based on the barometric pressure at which the measurements are obtained. Our objectives were (1) to report the normal values and variability of PEF and PIF of a Latin American population living at a moderate altitude (2240 m above sea level), (2) to analyze the adjustment of reference values obtained at sea level with those obtained in healthy subjects living at a moderate altitude, and (3) to assess the correlation between PEF obtained by spirometry (PEFs) and PEF obtained by mechanical devices (PEFm). In this prospective and transversal study, men and women with good respiratory health aged between 2.8 and 68 years old were invited to participate. Randomly, they underwent spirometry (to measure PEFs and PIFs) and mechanical flowmetry (to measure PEFm). A total of 314 subjects participated, with an average age of 24.3 ± 16.4 years; 59% were Women. The main determinants for the reference equations were age, weight, height and sex at birth. The agreement of the PEFm, PEFs and PIFs values was inconsistent with that reported by other authors, even at the same barometric pressure. The association between PEFm and PEFs was r = 0.91 (p < 0.001), and the correlation coefficient of concordance was 0.84. The PEFm, PEFs, and PIFs measurements in individuals living at moderate altitudes are different from those found by other authors in cities with different barometric pressures and ethnicities.


  • Quality of Pulmonary Function Tests in Participants with Down Syndrome

    by Rosario Fernández-Plata, Rogelio Pérez-Padilla, Rodrigo Del Río-Hidalgo, Cecilia García-Sancho, Laura Gochicoa-Rangel, Christian Rodríguez-Hernández, Luis Torre-Bouscoulet, David Martínez-Briseño